GNH USA

Europe — EMA

Mekostest 36

GNH USA supplies Mekostest 36 (Bacitracin), a dermatological topical for bacterial skin infections and inflammatory dermatitis.

Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio

Request sourcing

1
Pack/s

What is Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio?

Bacitracin, the active ingredient in Mekostest 36, is a dermatological antimicrobial presented as a topical formulation for skin use. It is employed to treat bacterial skin infections and inflammatory dermatoses in both adults and children. The combination formulation also includes anti‑inflammatory corticosteroids and antiseptic agents that broaden its therapeutic scope.

GNH USA supplies Mekostest 36 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across EU and global markets.

What is Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio used for?

Mekostest 36 is a topical combination used in dermatology to manage bacterial, inflammatory and fungal skin conditions.

- Impetigo: reduces bacterial colonisation and promotes lesion healing. - Atopic dermatitis flare: decreases inflammation, redness and itching. - Contact dermatitis: alleviates inflammatory response and prevents secondary infection. - Superficial fungal infection: provides antifungal activity to clear mild dermatophyte lesions. - Seborrheic dermatitis: controls microbial overgrowth and reduces scaling. - Minor burns: soothes irritation and helps prevent infection.

What are the side effects of Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio?

Mekostest 36 may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Skin irritation or burning sensation. - Pruritus or mild itching. - Erythema or redness at the application site. - Dryness or peeling of the skin. - Contact dermatitis. - Mild stinging.

Serious or Rare Side Effects: - Allergic reaction with swelling, hives or angioedema. - Secondary infection due to over‑growth of resistant organisms. - Systemic corticosteroid effects such as adrenal suppression when used over large areas. - Severe skin necrosis or ulceration. - Anaphylaxis (rare).

What precautions apply to Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio?

When using Mekostest 36, follow these safety measures.

- Avoid application on extensive broken skin: limit use to small affected areas. - Do not use on the face or mucous membranes unless directed by a clinician. - Limit duration of therapy: typically no longer than 2 weeks without medical review. - Monitor for signs of infection or allergic reaction and discontinue if they occur. - Contraindicated in patients with known hypersensitivity to any component. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio interact with?

Mekostest 36 can interact with other medications applied to the skin or taken systemically.

Major Interactions (Avoid): - Concurrent use of systemic corticosteroids: may increase risk of systemic steroid effects. - Other topical antibiotics: can promote resistant bacterial strains. - Immunosuppressive agents: heightened risk of opportunistic skin infections.

Moderate Interactions (Monitor Closely): - Occlusive dressings: may enhance percutaneous absorption of corticosteroids. - Topical antifungal agents: assess for additive irritation. - Wound‑healing products containing zinc or copper: may interfere with clioquinol activity.

Frequently asked questions

What conditions is Mekostest 36 used for?+
Mekostest 36 is a topical combination indicated for bacterial skin infections such as impetigo, inflammatory dermatoses like atopic or contact dermatitis, and mild superficial fungal infections. It may also be employed for seborrheic dermatitis and minor burn care when a broad‑spectrum antimicrobial and anti‑inflammatory effect is desired.
How does the active ingredient bacitracin work in Mekostest 36?+
Bacitracin inhibits bacterial cell‑wall synthesis by interfering with the dephosphorylation of bactoprenol, a carrier molecule essential for peptidoglycan assembly. This action stops bacterial growth, allowing the immune system to clear the infection. In the combination product, bacitracin works alongside corticosteroids and antiseptics to provide a multi‑modal therapeutic effect.
What is the usual dose of Mekostest 36?+
The dosage of Mekostest 36 is determined by the prescribing healthcare professional based on the specific indication, severity, patient age and the size of the affected area. Typically, a thin layer is applied to the cleaned skin once or twice daily, but exact instructions should always follow the prescriber's order.
Is Mekostest 36 safe to use during pregnancy or breastfeeding?+
Safety data for Mekostest 36 in pregnancy and lactation are limited. Because the product contains corticosteroids and multiple antimicrobial agents, it should be used only if the potential benefit outweighs any possible risk. Pregnant or nursing women should discuss use with their physician before applying the medication.
How do I order Mekostest 36 from GNH USA?+
To request Mekostest 36, visit the product page on gnh-usa.com, enter the required quantity and submit the enquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Mekostest 36 compare with other topical antibiotics?+
Mekostest 36 offers a broader spectrum than single‑agent topical antibiotics because it combines bacitracin with additional corticosteroids, antiseptics and an antifungal component. This multi‑ingredient approach can address mixed bacterial‑fungal infections and inflammatory skin conditions in one formulation, whereas many alternatives target only one type of pathogen or inflammation.
What are the storage and handling requirements for Mekostest 36?+
Store Mekostest 36 at room temperature, preferably below 25 °C. Keep the tube or container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use. Do not freeze the product, and discard any portion that appears discoloured or contaminated.
How is Mekostest 36 applied?+
Mekostest 36 is applied topically to the affected skin area. Clean and gently dry the area, then spread a thin, even layer of the cream or ointment as directed by the prescriber, usually once or twice daily. Wash hands before and after application unless the hands are the treatment site.
What are the most serious risks associated with Mekostest 36?+
Serious risks include allergic reactions such as hives, swelling or anaphylaxis, secondary infections due to resistant organisms, and systemic corticosteroid effects like adrenal suppression when used over large body surfaces or for prolonged periods. Patients should seek immediate medical attention if they experience severe skin reactions or systemic symptoms.
Who should not use Mekostest 36?+
Mekostest 36 should be avoided in individuals with known hypersensitivity to any of its components, including bacitracin, corticosteroids, bronopol, chlorquinaldol or clioquinol. It is also contraindicated on extensive broken skin, on the face or mucous membranes unless specifically prescribed, and in patients receiving systemic immunosuppressive therapy without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Bacitracin, Hydrocortisone Butyrate, Tixocortol Pivalate, Bronopol, Budesonide, Chlorquinaldol, Clio
Route
Cutaneous Use
Manufacturer
Smartpractice Denmark Aps
Origin
EU